Halozyme Therapeutics
-$0.79 (-1.91%) As of 7:47 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.
About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development and commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment.
CEO
Helen I. Torley
Employees
136
Headquarters
San Diego, California
Founded
1998
HALO Key Statistics
Market Cap
5.77B
Price-Earnings Ratio
36.45
Dividend Yield
—
Average Volume
855.12K
High Today
$41.55
Low Today
$40.54
Open Price
$41.55
Volume
366.81K
52 Week High
$56.40
52 Week Low
$25.17
Analyst Ratings
85%
of 13 ratings
Buy
84.6%
Hold
7.7%
Sell
7.7%
HALO Earnings
-$0.24
$0.02
$0.27
$0.53
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 9, After Hours